A clinical breakthrough, explained so people trust it.
Breath Diagnostics is a medical-technology company whose OneBreath platform screens for early-stage lung cancer from a single exhale, and holds an FDA Breakthrough Device Designation. I designed and built the website that makes that science clear and credible to clinicians, investors, and the press.
- At a glance
- 2026
- Client
- Breath Diagnostics, Inc.
- Sector
- Medical technology
- Year
- 2026
- Role
- Website design & build
Turning rigorous science into a story people trust.
OneBreath is a genuinely complex diagnostic: microreactor chemistry, mass spectrometry, and a large clinical validation behind it. The site had to convey that rigor without burying a non-specialist reader.
The design leads with the human promise of early detection, then lets the clinical depth, the validation, and the team carry the credibility.
- FDA
- Breakthrough Device Designation
- 94% / 85%
- sensitivity / specificity (OneBreath)
- 800+
- patients in clinical validation
Hard science,high stakes, mixed audience.
A diagnostics company has to satisfy clinicians and investors who want rigor, and reassure patients who want hope, all on the same site. The challenge was presenting clinical-grade detail and a warm, human promise without either one undermining the other.
- Deeply technical chemistry to explain simply
- Clinical credibility that cannot be overstated
- Investors, clinicians, and patients on one site
- A regulated space where wording matters
What I built,and how it came together.
The buildA credible, human site for a clinical breakthrough.
A site that opens with the promise of early detection, then carries the technology, the clinical validation, the team, and the latest milestones.
- Clear explainer of the OneBreath technology
- Clinical validation and credibility sections
- Team and leadership profiles
- News and milestone announcements
- Responsive build with a content system
- 01Frame the story
Lead with the human promise, support it with clinical rigor.Narrative · Information architecture · Design system
- 02Explain the science
Translate microreactor chemistry and MS analysis for a mixed audience.Explainers · Diagrams · Copy structure
- 03Build it
A responsive site with team, blog, and news systems.Build · CMS · Profiles
- 04Launch
Shipped to support clinical, investor, and press audiences.Launch · Handoff · SEO
Clinical rigor, human stakes,on one credible page.
Lead with the promise
The site opens with what matters to a human: one breath could save your life. The chemistry, the mass spectrometry, and the clinical validation stand behind that sentence rather than in front of it, so a patient and a pulmonologist can both start at the same headline.
Explain without diluting
OneBreath captures volatile organic compounds from a single exhale in a patented microreactor and reads them by mass spectrometry. The site translates that pipeline step by step for a mixed audience, with the sensitivity and specificity figures stated plainly and attributed to the company's own validation work.
A regulated voice
In diagnostics, wording is a compliance surface. Every claim stays inside what the FDA Breakthrough Device designation and the published studies support, and the clinical story is kept cleanly separate from the investment material.
Built for the raise
The investors page carries the company's live offering with its own capture flow, so clinical credibility and the funding motion reinforce each other instead of competing for the same screen.
The work
Visit breathdiagnostics.comRigor and hopeon the same page.
The site gives Breath Diagnostics a credible home for a complex clinical story, legible to clinicians and investors while still reassuring to patients. The figures below are the company's own clinical results.
Start with a short call. Straight answer either way.
Tell me what you are trying to ship. We scope it, price it, and decide the right way in.
One letter, every Sunday.Working systems, not hot takes.
Weekly. No spam. Unsubscribe anytime.